
Hi-Sci Limited
Using exosome based targeted drug delivery to treat inflammatory diseases.
Advancing drug delivery by harnessing the power of mesenchymal stem cell derived exosomes
Hi-Sci Limited is poised to revolutionise the drug delivery landscape by pioneering the development of innovative drug delivery vehicles, leveraging the untapped potential of mesenchymal stem cell derived extracellular vesicles. Focusing on this cutting-edge technology, we aim to enhance the precision and efficiency of therapeutic delivery in inflammatory disease conditions, ultimately improving patient outcomes.
Our Technology and Services
Revolutionising Medicine with Engineered Exosome-Based Therapies
With a global reach and a commitment to innovation, Hi-Sci Solutions is shaping the future of targeted therapeutics—driving breakthroughs in Drug Delivery Systems, R&D, and Biotech consultancy.
Our Areas of Application
Pharma Companies
Drug Tech Firms
Government & NPOs
Clinical Research Organisations
Academic Research Institutions
Biotech Firms